{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:15:03Z","timestamp":1793643303720,"version":"4.5.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005716","name":"Babol University of Medical Sciences","doi-asserted-by":"publisher","award":["724132940"],"award-info":[{"award-number":["724132940"]}],"id":[{"id":"10.13039\/501100005716","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Extracorporeal blood purification has been proposed as one of the therapeutic approaches in patients with coronavirus infection, because of its beneficial impact on elimination of inflammatory cytokines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This controlled trial has been conducted on critically ill COVID-19 patients admitted in the state hospital affiliated to Babol University of Medical Sciences, Iran who received different antiviral and antibacterial drugs, and different modalities of respiratory treatments and did not have positive clinical improvement. No randomization and blindness was considered. All of the participants underwent three sessions of resin-directed hemoperfusion using continuous renal replacement therapy with a mode of continuous venovenous hemofiltration (CVVH).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Five men and five women with a mean age of 57.30\u2009\u00b1\u200918.07\u2009years have been enrolled in the study; and six of them have improved after the intervention. Peripheral capillary oxygen saturation (SpO2) changed after each session. Mean SpO2 before the three sessions of hemoperfusion was 89.60%\u2009\u00b1\u20093.94% and increased to 92.13%\u2009\u00b1\u20093.28% after them (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u20090.001). Serum IL-6 showed a reduction from 139.70\u2009\u00b1\u2009105.62 to 72.06\u2009\u00b1\u200965.87\u2009pg\/mL (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.073); and c-reactive protein decreased from 136.25\u2009\u00b1\u200984.39 to 78.25\u2009\u00b1\u200938.67\u2009mg\/L (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u20090.016).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Extracorporeal hemoadsorption could improve the general condition in most of recruited patients with severe coronavirus disease; however, large prospective multicenter trials in carefully selected patients are needed to definitely evaluate the efficacy of hemoperfusion in COVID-19 patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      The research protocol has been registered in the website of Iranian Registry of Clinical Trials with the reference number\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/irct.ir\/trial\/46837\">IRCT20150704023055N2<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-020-02020-3","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T09:04:32Z","timestamp":1597914272000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID-19)"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5504-4612","authenticated-orcid":false,"given":"Masoumeh","family":"Asgharpour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1049-1267","authenticated-orcid":false,"given":"Hamed","family":"Mehdinezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3044-1168","authenticated-orcid":false,"given":"Masoumeh","family":"Bayani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8701-7267","authenticated-orcid":false,"given":"Mahmoud Sadeghi Haddad","family":"Zavareh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7542-7936","authenticated-orcid":false,"given":"Seyed Hossein","family":"Hamidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3720-3077","authenticated-orcid":false,"given":"Roghayeh","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4296-2836","authenticated-orcid":false,"given":"Reza","family":"Ghadimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2233-8726","authenticated-orcid":false,"given":"Ali","family":"Bijani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7868-9360","authenticated-orcid":false,"given":"Simin","family":"Mouodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,20]]},"reference":[{"key":"2020_CR1","unstructured":"World Health Organization. Coronavirus health topics: World Health Organization; 2020. Available from: https:\/\/www.who.int\/health-topics\/coronavirus."},{"key":"2020_CR2","doi-asserted-by":"publisher","first-page":"102433","DOI":"10.1016\/j.jaut.2020.102433","volume":"26","author":"HA Rothan","year":"2020","unstructured":"Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;26:102433. https:\/\/doi.org\/10.1016\/j.jaut.2020.102433.","journal-title":"J Autoimmun"},{"key":"2020_CR3","first-page":"1","volume":"13","author":"KW Chan","year":"2020","unstructured":"Chan KW, Wong VT, Tang SCW. COVID-19: an update on the epidemiological, clinical, preventive and therapeutic evidence and guidelines of integrative Chinese-Western medicine for the management of 2019 novel Coronavirus disease. Am J Chin Med. 2020;13:1\u201326.","journal-title":"Am J Chin Med"},{"key":"2020_CR4","volume-title":"Coronavirus disease 2019 (COVID-19) situation report","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Coronavirus disease 2019 (COVID-19) situation report. 2020. Contract No: 96. Data as received by WHO from national authorities by 10:00 CEST, 25 April 2020. Available from: https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200425-sitrep-96-covid-19.pdf?sfvrsn=a33836bb_2."},{"key":"2020_CR5","volume-title":"Features, evaluation and treatment Coronavirus (COVID-19)","author":"M Cascella","year":"2020","unstructured":"Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Napoli RD. Features, evaluation and treatment Coronavirus (COVID-19); 2020."},{"issue":"10223","key":"2020_CR6","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2013506.","journal-title":"Lancet"},{"issue":"10","key":"2020_CR7","doi-asserted-by":"publisher","first-page":"e0187015","DOI":"10.1371\/journal.pone.0187015","volume":"12","author":"D Schadler","year":"2017","unstructured":"Schadler D, Pausch C, Heise D, Meier-Hellmann A, Brederlau J, Weiler N, et al. The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: a randomized controlled trial. PLoS One. 2017;12(10):e0187015.","journal-title":"PLoS One"},{"key":"2020_CR8","doi-asserted-by":"publisher","unstructured":"Naicker S, Yang C-W, Hwang S-J, Liu B-C, Chen J-H, Jha V. The Novel Coronavirus 2019 epidemic and kidneys. Kidney Int. 2020;97:824\u20138. https:\/\/doi.org\/10.1016\/j.kint.2020.03.001.","DOI":"10.1016\/j.kint.2020.03.001"},{"issue":"Suppl 3","key":"2020_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000499520","volume":"47","author":"C Monard","year":"2019","unstructured":"Monard C, Rimmele T, Ronco C. Extracorporeal blood purification therapies for Sepsis. Blood Purif. 2019;47(Suppl 3):1\u201314.","journal-title":"Blood Purif"},{"key":"2020_CR10","doi-asserted-by":"publisher","unstructured":"Ronco C, Reis, T. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. Nat Rev Nephrol. 2020;16:308\u201310. https:\/\/doi.org\/10.1038\/s41581-020-0284-7.","DOI":"10.1038\/s41581-020-0284-7"},{"key":"2020_CR11","doi-asserted-by":"publisher","first-page":"108408","DOI":"10.1016\/j.clim.2020.108408","volume":"214","author":"J Ma","year":"2020","unstructured":"Ma J, Xia P, Zhou Y, Liu Z, Zhou X, Wang J, et al. Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19. Clin Immunol. 2020;214:108408.","journal-title":"Clin Immunol"},{"issue":"1","key":"2020_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13613-019-0491-1","volume":"9","author":"PM Honor\u00e9","year":"2019","unstructured":"Honor\u00e9 PM, De Bels D, Barreto Gutierrez L, Spapen HD. Hemoadsorption therapy in the critically ill: solid base but clinical haze. Ann Intensive Care. 2019;9(1):22.","journal-title":"Ann Intensive Care"},{"issue":"1\u20132","key":"2020_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000502680","volume":"49","author":"S Harm","year":"2020","unstructured":"Harm S, Schildbock C, Hartmann J. Cytokine removal in extracorporeal blood purification: an in vitro study. Blood Purif. 2020;49(1\u20132):33\u201343.","journal-title":"Blood Purif"},{"key":"2020_CR14","doi-asserted-by":"publisher","unstructured":"Kellum JA, Bellomo R, Ronco C. Continuous renal replacement therapy. In: JA Kellum, editor. Pittsburgh Critical Care Medicine. Second ed. Oxford University Press; 2016. https:\/\/doi.org\/10.1093\/med\/9780190225537.001.0001.","DOI":"10.1093\/med\/9780190225537.001.0001"},{"issue":"3","key":"2020_CR15","doi-asserted-by":"publisher","first-page":"e62674","DOI":"10.5812\/ircmj.62674","volume":"20","author":"H Argani","year":"2018","unstructured":"Argani H, Alirezaei A, Ghorbanihaghjo A, Azizi T, Asgharpour M, et al. Comparing the serum levels of Adipocytokines in the renal transplant recipients and healthy individuals: a case-control study. Iran Red Crescent Med J. 2018;20(3):e62674. https:\/\/doi.org\/10.5812\/ircmj.62674.","journal-title":"Iran Red Crescent Med J"},{"key":"2020_CR16","unstructured":"Epstein SK. Weaning from mechanical ventilation: Readiness testing. In: Parsons PE, Finlay G, editor. 2018. Available from: https:\/\/www.uptodate.com\/contents\/weaning-from-mechanical-ventilation-readiness-testing#subscribe. Last updated: Dec 04, 2018."},{"issue":"6","key":"2020_CR17","first-page":"607","volume":"80","author":"Q Ye","year":"2020","unstructured":"Ye Q, Wang B, Mao J. The pathogenesis and treatment of the \u2018cytokine Storm\u2019 in COVID-19. J Inf Secur. 2020;80(6):607\u201313.","journal-title":"J Inf Secur"},{"issue":"10229","key":"2020_CR18","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033\u20134.","journal-title":"Lancet"},{"key":"2020_CR19","first-page":"2020","volume":"105954","author":"C Zhang","year":"2020","unstructured":"Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality. Int J Antimicrob Agents. 2020;105954:2020.","journal-title":"Int J Antimicrob Agents"},{"key":"2020_CR20","first-page":"1022","volume":"14","author":"B Russell","year":"2020","unstructured":"Russell B, Moss C, George G, Santaolalla A, Cope A, Papa S, et al. Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence. Ecancermedicalscience. 2020;14:1022.","journal-title":"Ecancermedicalscience"},{"issue":"4","key":"2020_CR21","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.medmal.2020.03.007","volume":"50","author":"L Wang","year":"2020","unstructured":"Wang L. C-reactive protein levels in the early stage of COVID-19. Med Mal Infect. 2020;50(4):332\u20134.","journal-title":"Med Mal Infect"},{"key":"2020_CR22","doi-asserted-by":"publisher","first-page":"2000547","DOI":"10.1183\/13993003.00547-2020","volume":"55","author":"W-J Guan","year":"2020","unstructured":"Guan W-J, Liang W-H, Zhao Y, Liang H-R, Chen Z-S, Li Y-M, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: a Nationwide analysis. Eur Respir J. 2020;55:2000547.","journal-title":"Eur Respir J"},{"issue":"1","key":"2020_CR23","first-page":"11","volume":"7","author":"Y-R Guo","year":"2020","unstructured":"Guo Y-R, Cao Q-D, Hong Z-S, Tan Y-Y, Chen S-D, Jin H-J, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak \u2013 an update on the status. Mil Med Res. 2020;7(1):11.","journal-title":"Mil Med Res"},{"issue":"1","key":"2020_CR24","first-page":"e35","volume":"8","author":"A Emami","year":"2020","unstructured":"Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis. Arch Acad Emerg Med. 2020;8(1):e35 e.","journal-title":"Arch Acad Emerg Med"},{"key":"2020_CR25","doi-asserted-by":"publisher","unstructured":"Zhang Y, Yu L, Tang L, Zhu M, Jin Y, Wang Z, et al. A promising anti-cytokine-storm targeted therapy for COVID-19: the artificial-liver blood-purification system. Engineering (Beijing). 2020. https:\/\/doi.org\/10.1016\/j.eng.2020.03.006.","DOI":"10.1016\/j.eng.2020.03.006"},{"issue":"6","key":"2020_CR26","doi-asserted-by":"publisher","first-page":"399","DOI":"10.4103\/0972-5229.133939","volume":"18","author":"SK Garg","year":"2014","unstructured":"Garg SK, Goyal PK, Kumar R, Juneja D, Bhasin A, Singh O. Management of life-threatening calcium channel blocker overdose with continuous veno-venous hemodiafiltration with charcoal hemoperfusion. Indian J Crit Care Med. 2014;18(6):399\u2013401. https:\/\/doi.org\/10.4103\/0972-5229.133939.","journal-title":"Indian J Crit Care Med"},{"issue":"4","key":"2020_CR27","doi-asserted-by":"publisher","first-page":"231","DOI":"10.4103\/0972-5229.106511","volume":"16","author":"D Juneja","year":"2012","unstructured":"Juneja D, Singh O, Bhasin A, Gupta M, Saxena S, Chaturvedi A. Severe suicidal digoxin toxicity managed with resin hemoperfusion: a case report. Indian J Crit Care Med. 2012;16(4):231\u20133. https:\/\/doi.org\/10.4103\/0972-5229.106511.","journal-title":"Indian J Crit Care Med"},{"issue":"1","key":"2020_CR28","doi-asserted-by":"publisher","first-page":"e000420","DOI":"10.1136\/bmjresp-2019-000420","volume":"6","author":"MJD Griffiths","year":"2019","unstructured":"Griffiths MJD, McAuley DF, Perkins GD, Barrett N, Blackwood B, Boyle A, et al. Guidelines on the management of acute respiratory distress syndrome. BMJ Open Respir Res. 2019;6(1):e000420 e.","journal-title":"BMJ Open Respir Res"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-02020-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-020-02020-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-02020-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T19:38:04Z","timestamp":1629401884000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-020-02020-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,20]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2020"],"URL":"https:\/\/doi.org\/10.1186\/s12882-020-02020-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-29229\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-29229\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-29229\/v3","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,20]]},"assertion":[{"value":"11 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research has been approved by the Ethics Committee of Babol University of Medical Sciences with the approval code IR.MUBABOL.HRI.REC.1399.038. Also, the research protocol has been registered in the website of Iranian Registry of Clinical Trials with the reference number IRCT20150704023055N2. A written informed consent was obtained from all participants or their proxies.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants or their proxies gave written consent for their personal or clinical details along with any identifying images to be published in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests<b>.<\/b>","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"356"}}